Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17763246 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL120131 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL414426 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL17763250 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL118864 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL7259121 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL17763256 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL17763261 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL43306 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 | |
| SCHEMBL120451 | 1.00 | CA2 (0.55) | CA2CA1GPR84FFAR1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1917 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240011976-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | BECKMAN COULTER, INC. | 2024-01-11 | — | — | US | claimed |
| CN-116997797-A | Additives for reducing non-specific interactions between fluorescent polymer conjugates and cells in biological samples | 贝克曼库尔特有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-4244625-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | Beckman Coulter, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| US-20230183549-A1 | COMPOSITIONS AND METHODS FOR REDUCING INJECTION PRESSURE IN RESOURCE RECOVERY OPERATIONS | SOLUGEN, INC. (US) | 2023-06-15 | — | — | US | claimed |
| US-20230183553-A1 | COMPOSITIONS AND METHODS FOR IRON CHELATION | SOLUGEN, INC. (US) | 2023-06-15 | — | — | US | claimed |
| CN-115487194-A | Aprepitant pharmaceutical composition and preparation method thereof | 江苏慧聚药业股份有限公司 | 2022-12-20 | — | — | CN | claimed |
| EP-4055127-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | Fernandes Serodio, Joao Carlos (GB) | 2022-09-14 | — | — | EP | claimed |
| CN-110820073-B | Preparation process of antibacterial primary polyester staple fiber | 杭州奔马化纤纺丝有限公司 | 2022-05-31 | — | — | CN | claimed |
| WO-2022104147-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | BECKMAN COULTER, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| CN-110923842-B | Preparation process of non-dyed primary polyester staple fiber | 杭州奔马化纤纺丝有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-1484521-A | Inhibitor or repairing agent for skin damage caused by dryness and method for evaluating the same | ������������ʽ���� | 2004-03-24 | — | — | CN | claimed |
| US-6685952-B1 | CONDITIONERS, SHAMPOOS, HAIR COLOR, SKIN LOTIONS; | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-03 | — | — | US | claimed |
| EP-1011624-B1 | PHOTOPROTECTANT COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOSITIONS FILTERING ULTRAVIOLET RADIATION AND AN AMPHIPHILIC CATIONIC OR DIPOLAR ION COMPOUND AND ITS USE | OREAL (FR) | 2003-11-12 | — | — | EP | claimed |
| US-20030069148-A1 | Mild cleansing composition having stable foam | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2003-04-10 | — | — | US | claimed |
| US-6375936-B1 | SUNSCREEN | L'OREAL (FR) | 2002-04-23 | — | — | US | claimed |
| CN-1273525-A | Sunscreen compositions comprising anionic surfactant, UV-radiation filtering compound and cationic or zwitterionic amphiphilic compound and use thereof | OREAL (FR) | 2000-11-15 | — | — | CN | claimed |
| EP-1011624-A1 | PHOTOPROTECTANT COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOSITIONS FILTERING ULTRAVIOLET RADIATION AND AN AMPHIPHILIC CATIONIC OR DIPOLAR ION COMPOUND AND ITS USE | L'OREAL (FR) | 2000-06-28 | — | — | EP | claimed |
| WO-2000002529-A1 | PHOTOPROTECTANT COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOSITIONS FILTERING ULTRAVIOLET RADIATION AND AN AMPHIPHILIC CATIONIC OR DIPOLAR ION COMPOUND AND ITS USE | L'OREAL (FR) | 2000-01-20 | — | — | WO | claimed |
| US-5958334-A | SOLID COMBINATION OF: AND ALKALINE EFFERVESCENT, ACID, OXIDIZING AGENT, AND AN ACTIVATOR, WITH A FOAM FORMING SURFACTANT; FOR USE IN TOILETS, URINALS, SEPTIC TANKS OR OTHER AQUEOUS BASED WASTE-PREVENTS ODORS | HADDON BRUCE ALEXANDER (AU) | 1999-09-28 | — | — | US | claimed |
| WO-1995016470-A1 | A COMBINATION CAPABLE OF FORMING AN ODOUR BARRIER AND METHODS OF USE | HADDON BRUCE ALEXANDER (AU) | 1995-06-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069148-A1 | Mild cleansing composition having stable foam | SMPD1, SGMS2, SMPD2 | CA2 1861/4885CA1 520/4885GPR84 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.